You are here: Industry Insights > spectra

News List

Clover Biopharmaceuticals Completes Enrollment of Adult and Elderly Population in SPECTRA Global Phase 2/3 Clinical Trial for its COVID-19 Vaccine Candidate prnasia
July 06, 2021
Clover Biopharmaceuticals, a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates to address the world's most life-threatening diseases and public health threats, today announced the completion of ...
European Pharmacopoeia adopts revised Raman spectroscopy chapter europeanpharmaceuticalreview
May 14, 2021
The revised Raman Spectroscopy chapter (2.2.48) will be released in October, with updates focusing on enhancing the reliability of the results.
First Participants Dosed in Adjuvanted S-Trimer COVID-19 Vaccine Candidate Trial americanpharmaceuticalreview
April 01, 2021
Clover Biopharmaceuticals and Dynavax Technologies announced the first participants have been dosed in Clover's SPECTRA trial (Study Evaluating Protective-Efficacy and Safety of Clover's Trimeric Recombinant Protein-based and Adjuvanted COVID-19 ...
Clover Biopharmaceuticals and Dynavax Announce First Participants Dosed in SPECTRA, a Global Phase 2/3 Clinical Trial for Adjuvanted S-Trimer COVID-19 Vaccine Candidate prnewswire
March 25, 2021
Clover Biopharmaceuticals, a global clinical-stage biotechnology company developing transformative biologics such as vaccines and therapeutics for the world's most debilitating diseases, and Dynavax Technologies Corporation, a biopharmaceutical ...
Using machine learning to interpret material spectra europeanpharmaceuticalreview
September 10, 2018
Researchers from the University of Tokyo have developed a method to use machine learning to interpret data from spectroscopy techniques…